Retatrutide 10mg

Retatrutide 10mg — Triple Agonist Peptide

Retatrutide (LY3437943) is a next-generation triple receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. It represents one of the most advanced peptides in current metabolic research.

Key Research Areas:

• Metabolic rate and energy expenditure
• Glucose homeostasis and insulin sensitivity
• Lipid metabolism and adipose tissue reduction
• Cardiovascular risk factor modulation

Product Details:

• Purity: ≥99% (HPLC verified)
• Amount: 10mg per vial
• Form: Lyophilized powder
• Storage: Store at -20°C, protect from light

For research purposes only. Not intended for human consumption.